Cu metallonucleases · “Synthesis and biological activity of Cu(II) metallonucleases that target tumour cells”
7РП — „Хора“ (Действия „Мария Кюри“)
- Период
- 2013-06-03 → 2015-06-02
- Финансиране от ЕС
- 191 938 €
- Участници
- 1
- Схема
- MC-IEF
Линиите свързват координатора с партньорите.
Накратко на български
Метални комплекси с мед и естрогени (като тестостерон и естрадиол) се тестват за способността им да се свързват и разрязват ДНК. Това помага за подобряване на точността, с която противораковите вещества разпознават и атакуват туморните клетки.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
“Synthesis and biological activity of Cu(II) metallonucleases that target tumour cells”
The Marie Curie project “Cu metallonucleases” aimed to investigate on the effect of estrogens ligands in the biological anticancer properties of Cu(II) complexes. It is well known that many cancer cells show overexpression of estrogen receptors in the cell membrane. Exploiting these particular features, the idea was to bioconjugate estrogens (testosterone and estradiol) to Cu(II) complexes to increase the selectivity for tumoral cells. Six complexes have been synthesised (see attachment), which differ for the presence of testosterone or estradiol, phenanthroline or necuproine, halogens or phenanthroline in the coordination sphere of the metal. The complexes have been fully characterised through ESI Mass Spectroscopy, Elemental Analyses, Cyclic Voltammetry and IR Spectroscopy. DNA binding properties have been investigated using different techniques and different types of DNA. Competition studies with ethidium bromide (major groove binder), Hoechst dye (minor groove binder), viscosity, DNA melting point analyses show that all the complexes can bind quite strongly with the nuclear DNA. From melting point analyses with the pure oligonucleotides Poly [d(A-T)2] and poly[d(G-C)2] is clearly demonstrated that the complexes bind stronger to the major groove of the DNA (poly[d(G-C)2]) than to the minor groove of the DNA (Poly [d(A-T)2]). DNA cleavage studies investigated via gel-electrophoresis, show that the complexes can cleave the DNA at low micromolar concentration with a oxidative mechanism. For the DNA binding and cleavage analyses a similar trend is observed for the complexes, 5 6 1 2 3 4. The necuproine scaffold in complexes 3 and 4 decreases the binding and the cleavage (as stated by previous work in literature). The presence of a phenanthroline in the coordination sphere of the complexes (5 and 6) definitively increases the binding properties to DNA (major intercalation due to the planar phen ring) and the cleavage activity. Cytotoxicity analyses versus different tumoral cell lines are currently undergoing. In conclusion, the effect of estrogen ligands improve the binding and the cleavage activity of Cu(II) complexes with very high binding constant for complexes 5 and 6.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Dr. Diego Montagner, an Italian national who is working as a postdoc in the group of Prof. B. Longato (Padua University), is making an application to this programme to move to NUI Galway in Ireland, where he is currently spending a period as Visiting Scientist in the group of Dr. A. Erxleben, to carry out a project for 24 months in the area of medicinal inorganic chemistry.This proposal specifically deals with the synthesis of Cu(II) complexes that selectively target tumour cells and act as artificial metallonucleases, i.e. cleave the DNA of the tumour cell through a hydrolytic mechanism. Specific carrier molecules such as estrogens will be conjugated to the complexes to increase the selectivity. The catalytic activity will be tested studying DNA models (like simple phosphate diesters with good leaving groups), short oligonucleotides and supercoiled plasmid DNA. Biological tests will be performed on different tumoral cell lines, including cisplatin-resistant ones.The fellow has already an excellent background in coordination chemistry and this project will allow him to deepen and expand his skills in organic synthesis. He will learn new analytical techniques and at the final stage of the project he will enter into the biological field. Besides contributing to his overall scientific growth, this experience will be important for his long-term plans to focus his research interests on biological aspects of medicinal chemistry, such as drug-biomolecule interactions.He proposes to join NUI Galway which is strategically developing strength in Biomedical Research and Cancer, a very important and challenging branch of Chemistry/Biochemistry research in Europe. NUI Galway will also provide training in transferable skills and mentoring to Dr. Montagner. Both the scientific and personal training will contribute to his personal development and will allow him to reach professional maturity and to become an indipendent researcher.
Оригинален текст от CORDIS (на английски).
Участници
- UNIVERSITY OF GALWAY · GalwayКоординаторИрландия
Връзки
Данни: CORDIS, © Европейски съюз
